136 related articles for article (PubMed ID: 23288633)
1. Novel antineoplastics targeting genetic changes in colorectal cancer.
Joudeh J; Allen JE; Das A; Prabhu V; Farbaniec M; Adler J; El-Deiry WS
Adv Exp Med Biol; 2013; 779():1-34. PubMed ID: 23288633
[TBL] [Abstract][Full Text] [Related]
2. The Treatment of Colorectal Cancer During Pregnancy: Cytotoxic Chemotherapy and Targeted Therapy Challenges.
Rogers JE; Dasari A; Eng C
Oncologist; 2016 May; 21(5):563-70. PubMed ID: 27000464
[TBL] [Abstract][Full Text] [Related]
3. Development of novel targeted agents in the treatment of metastatic colorectal cancer.
Berge E; Thompson C; Messersmith W
Clin Colorectal Cancer; 2011 Dec; 10(4):266-78. PubMed ID: 21903484
[TBL] [Abstract][Full Text] [Related]
4. Targeting NF-kappaB for colorectal cancer.
Sakamoto K; Maeda S
Expert Opin Ther Targets; 2010 Jun; 14(6):593-601. PubMed ID: 20367537
[TBL] [Abstract][Full Text] [Related]
5. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer.
Song L; Li Y; He B; Gong Y
Clin Colorectal Cancer; 2015 Sep; 14(3):133-45. PubMed ID: 25799881
[TBL] [Abstract][Full Text] [Related]
6. Translation initiation in colorectal cancer.
Parsyan A; Hernández G; Meterissian S
Cancer Metastasis Rev; 2012 Jun; 31(1-2):387-95. PubMed ID: 22418835
[TBL] [Abstract][Full Text] [Related]
7. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
[TBL] [Abstract][Full Text] [Related]
8. Novel and Emerging Targeted Therapies of Colorectal Cancer.
Finnberg N; Gokare P; El-Deiry WS
Curr Clin Pharmacol; 2015; 10(4):279-98. PubMed ID: 26548905
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics of intrinsic and acquired pharmacoresistance in colorectal cancer: Toward targeted personalized therapy.
De Mattia E; Cecchin E; Toffoli G
Drug Resist Updat; 2015 May; 20():39-70. PubMed ID: 26027741
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor: pathway, therapies, and pipeline.
Goffin JR; Zbuk K
Clin Ther; 2013 Sep; 35(9):1282-303. PubMed ID: 24054705
[TBL] [Abstract][Full Text] [Related]
11. BRAF in metastatic colorectal cancer: the future starts now.
Orlandi A; Calegari A; Inno A; Berenato R; Caporale M; Niger M; Bossi I; Di Bartolomeo M; de Braud F; Pietrantonio F
Pharmacogenomics; 2015 Dec; 16(18):2069-81. PubMed ID: 26615988
[TBL] [Abstract][Full Text] [Related]
12. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
[TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer models for novel drug discovery.
Golovko D; Kedrin D; Yilmaz ÖH; Roper J
Expert Opin Drug Discov; 2015; 10(11):1217-29. PubMed ID: 26295972
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic role and therapeutic target of leptin signaling in colorectal cancer.
Zhou W; Tian Y; Gong H; Guo S; Luo C
Expert Opin Ther Targets; 2014 Aug; 18(8):961-71. PubMed ID: 24946986
[TBL] [Abstract][Full Text] [Related]
15. The role of the PI3K pathway in colorectal cancer.
Papadatos-Pastos D; Rabbie R; Ross P; Sarker D
Crit Rev Oncol Hematol; 2015 Apr; 94(1):18-30. PubMed ID: 25591826
[TBL] [Abstract][Full Text] [Related]
16. The implications of colorectal cancer molecular biology in clinical practice.
Kargozaran H; Kahlenberg M; Khatri VP
Surg Oncol Clin N Am; 2008 Apr; 17(2):341-55, viii-ix. PubMed ID: 18375356
[TBL] [Abstract][Full Text] [Related]
17. A combination of eicosapentaenoic acid-free fatty acid, epigallocatechin-3-gallate and proanthocyanidins has a strong effect on mTOR signaling in colorectal cancer cells.
D'Angelo L; Piazzi G; Pacilli A; Prossomariti A; Fazio C; Montanaro L; Graziani G; Fogliano V; Munarini A; Bianchi F; Belluzzi A; Bazzoli F; Ricciardiello L
Carcinogenesis; 2014 Oct; 35(10):2314-20. PubMed ID: 25123131
[TBL] [Abstract][Full Text] [Related]
18. From Molecular Biology to Clinical Trials: Toward Personalized Colorectal Cancer Therapy.
Palma S; Zwenger AO; Croce MV; Abba MC; Lacunza E
Clin Colorectal Cancer; 2016 Jun; 15(2):104-15. PubMed ID: 26777471
[TBL] [Abstract][Full Text] [Related]
19. On target? Strategies and progress in the development of therapies for colorectal cancer targeted against WNT signalling.
McDonald SL; Silver AR
Colorectal Dis; 2011 Apr; 13(4):360-9. PubMed ID: 20015264
[TBL] [Abstract][Full Text] [Related]
20. New strategies for colorectal cancer prevention and treatment.
Saha D; Roman C; Beauchamp RD
World J Surg; 2002 Jul; 26(7):762-6. PubMed ID: 11948369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]